Relay Therapeutics (RLAY) Change in Cash (2019 - 2026)
Relay Therapeutics (RLAY) reported Change in Cash of $120.6 million for Q1 2026, up 492.16% year-over-year from $20.4 million in Q1 2025, and up 1523.84% on a QoQ basis from -$8.5 million in Q4 2025.
Relay Therapeutics (RLAY) has 8 years of Change in Cash data on file, last reported at $120.6 million in Q1 2026.
- Quarterly Change in Cash rose 492.16% year-over-year to $120.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110.3 million (up 284.04% YoY) and the FY2025 annual result came in at -$41.1 million, down 104.88% from the prior year.
- Change in Cash improved to $120.6 million in Q1 2026 per RLAY's latest filing, from -$8.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $246.9 million in Q3 2022 and bottomed at -$202.8 million in Q4 2022.
- The 5-year median for Change in Cash is -$8.5 million (2025), against an average of -$4.5 million.
- Peak annual rise in Change in Cash reached 883.58% in 2022, while the deepest fall reached 1131.23% in 2022.
- Tracing RLAY's Change in Cash over 5 years: stood at -$202.8 million in 2022, then jumped by 96.26% to -$7.6 million in 2023, then sank by 269.73% to -$28.1 million in 2024, then jumped by 69.83% to -$8.5 million in 2025, then soared by 1523.84% to $120.6 million in 2026.
- Per Business Quant, the three latest RLAY Change in Cash figures stand at $120.6 million (Q1 2026), -$8.5 million (Q4 2025), and -$22.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Relay Therapeutics | 2.53 Bn | 2.53 Bn | - | 120.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.57 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Sep 30, 2025 | -22.38 Mn |
| Jun 30, 2025 | 20.54 Mn |
| Mar 31, 2025 | -30.75 Mn |
| Dec 31, 2024 | -28.07 Mn |
| Sep 30, 2024 | 17.64 Mn |
| Jun 30, 2024 | -18.74 Mn |
| Mar 31, 2024 | 9.13 Mn |
| Dec 31, 2023 | -7.59 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | -15.24 Mn |
| Mar 31, 2023 | 9.48 Mn |
| Dec 31, 2022 | -202.85 Mn |
| Sep 30, 2022 | 246.91 Mn |
| Jun 30, 2022 | -11.71 Mn |
| Mar 31, 2022 | -160.67 Mn |
| Dec 31, 2021 | 51.56 Mn |
| Sep 30, 2021 | -31.51 Mn |
| Jun 30, 2021 | -951,000.00 |
| Mar 31, 2021 | -184.93 Mn |
| Dec 31, 2020 | -111.64 Mn |
| Sep 30, 2020 | 422.23 Mn |
| Jun 30, 2020 | 66.71 Mn |
| Mar 31, 2020 | 28.39 Mn |
| Dec 31, 2019 | 12.91 Mn |
| Sep 30, 2019 | -10.31 Mn |